AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Van den Eynde, BJ Morel, S
Citation: Bj. Van Den Eynde et S. Morel, Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome, CURR OP IM, 13(2), 2001, pp. 147-153

Authors: Probst-Kepper, M Stroobant, V Kridel, R Gaugler, B Landry, C Brasseur, F Cosyns, JP Weynand, B Boon, T Van den Eynde, BJ
Citation: M. Probst-kepper et al., An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes, J EXP MED, 193(10), 2001, pp. 1189-1198

Authors: Morel, S Levy, F Burlet-Schiltz, O Brasseur, F Probst-Kepper, M Peitrequin, AL Monsarrat, B Van Velthoven, R Cerottini, JC Boon, T Gairin, JE Van den Eynde, BJ
Citation: S. Morel et al., Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells, IMMUNITY, 12(1), 2000, pp. 107-117

Authors: Heidecker, L Brasseur, F Probst-Kepper, M Gueguen, M Boon, T Van den Eynde, BJ
Citation: L. Heidecker et al., Cytolytic T lymphocytes raised against a human bladder carcinoma recognizean antigen encoded by gene MAGE-A12, J IMMUNOL, 164(11), 2000, pp. 6041-6045

Authors: Bilsborough, J Van Pel, A Uyttenhove, C Boon, T Van den Eynde, BJ
Citation: J. Bilsborough et al., Identification of a second major tumor-specific antigen recognized by CTLson mouse mastocytoma P815, J IMMUNOL, 162(6), 1999, pp. 3534-3540

Authors: Morel, S Ooms, A Van Pel, A Wolfel, T Brichard, VG van der Bruggen, P Van den Eynde, BJ Degiovanni, G
Citation: S. Morel et al., A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes, INT J CANC, 83(6), 1999, pp. 755-759

Authors: Brandle, D Bilsborough, J Rulicke, T Uyttenhove, C Boon, T Van den Eynde, BJ
Citation: D. Brandle et al., The shaved tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection, EUR J IMMUN, 28(12), 1998, pp. 4010-4019
Risultati: 1-7 |